Prevalence and risk factors for Chlamydia trachomatis seropositivity and seropersistence among women: A prospective cohort study
PLOS One · 2025
DOI: 10.1371/journal.pone.0328449 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, 2025. Verfasst von Zoïe W Alexiou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Hauptthemen laut MEDLINE: Chlamydia trachomatis, Chlamydia Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Ministerie van Volksgezondheid, Welzijn en Sport.
Abstract (Originalsprache)
Introduction
Population-based Chlamydia trachomatis (CT) serology studies help evaluate the effectiveness of CT-control strategies. Determinants of CT seropersistence over time are largely unknown, but may include host genetic factors. This study aims to assess seropositivity, map antibody trajectories, and identify determinants of seropositivity and seropersistence.
Methods
We analyzed anti-chlamydial immunoglobulin G levels in serum of women of reproductive age who participated in a prospective cohort and CT screening study. CT history was determined using screening results and self-reported diagnoses from sexual debut onward. We assessed seropersistence for n = 1,405 participants with samples at baseline and after six years, and seropositivity for n = 2,997 participants with baseline samples. Multivariable logistic regression identified demographic, behavioral, and host single nucleotide polymorphism (SNP) factors associated with seropersistence and seropositivity.
Results
Among seropositive women at baseline, 42.0% (n = 118/281) were seropositive at follow-up. Seropersistence was more often found in women who reported treated asymptomatic and symptomatic CT infections as compared to those who did not (aOR: 3.74, 95%CI: 1.75–8.15 and 4.79, 95%CI: 2.42–9.47, respectively). Other associated factors were higher baseline antibody titers, carrying SNPs in TLR2 (aOR: 3.06, 95%CI: 1.31–7.36) and TLR9 (2.09, 95%CI: 1.09–4.08) genes and practical education (aOR: 3.16, 95%CI: 1.56–6.64). Seropositivity (24.9%, n = 748/2,997) was associated with a CCR5 deletion (aOR: 0.65, 95%CI: 0.42–0.99).
Conclusions
CT seropersistence was more often found in women who reported treated CT infections as compared to women who did not report having had a CT infection or receiving treatment for it. Genetic predisposition and behavioral factors are linked to diversity in seropersistence patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
- Institute for Public Health Genomics (IPHG), GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.
- Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
- Department of Sexual Health, Infectious Diseases and Environmental Health, Living Lab Public Health Mosa, Public Health Service South Limburg, Heerlen, The Netherlands.
- Department of Medical Microbiology, Infectious Diseases and Infection Prevention, National Chlamydia trachomatis Reference Laboratory, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Ce…
- Department of Health Promotion, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands.
ORCID-Profile: Zoïe W Alexiou, Christian J P A Hoebe
Förderung
- ZonMw
- Ministerie van Volksgezondheid, Welzijn en Sport
Zitieren
APA
Alexiou, Z. W., Hoenderboom, B. M., Hoebe, C. J. P. A., Scholte, I., Sheombarsing, R., Dukers-Muijrers, N. H. T. M., van Benthem, B. H. B., & Morré, S. A. (2025). Prevalence and risk factors for Chlamydia trachomatis seropositivity and seropersistence among women: A prospective cohort study. PLOS One. https://doi.org/10.1371/journal.pone.0328449
Vancouver
Alexiou ZW, Hoenderboom BM, Hoebe CJPA, Scholte I, Sheombarsing R, Dukers-Muijrers NHTM, et al. Prevalence and risk factors for Chlamydia trachomatis seropositivity and seropersistence among women: A prospective cohort study. PLOS One. 2025. doi:10.1371/journal.pone.0328449
BibTeX
@article{Alexiou2025,
author = {Alexiou, Zoïe W and Hoenderboom, Bernice M and Hoebe, Christian J P A and Scholte, Iris and Sheombarsing, Reshtrie and Dukers-Muijrers, Nicole H T M and van Benthem, Birgit H B and Morré, Servaas A},
title = {Prevalence and risk factors for Chlamydia trachomatis seropositivity and seropersistence among women: A prospective cohort study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0328449}
}
EUVIMED